BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UW Department of Psychiatry - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.psychiatry.wisc.edu
X-WR-CALDESC:Events for UW Department of Psychiatry
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20180311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20181104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190912T170000
DTEND;TZID=America/Chicago:20190912T190000
DTSTAMP:20260525T105855
CREATED:20190416T153918Z
LAST-MODIFIED:20190904T191128Z
UID:3622-1568307600-1568314800@www.psychiatry.wisc.edu
SUMMARY:Greenfield Memorial Lecture: Progress in Suicide Prevention | Charles B. Nemeroff\, MD\, PhD
DESCRIPTION:Progress in Suicide Prevention\nTHURSDAY\, SEPTEMBER 12\, 2019\n5:30 – 7:00PM\nWisconsin Psychiatric Institute and Clinic\n6001 Research Park Boulevard\, Room 1616\n* Light refreshments will be served * \nCharles B. Nemeroff\, MD\, PhD\nProfessor and Acting Chair\nDepartment of Psychiatry\nAssociate Chair for Research\nDirector\, Institute of Early Life Adversity Research\nDell Medical School\, The University of Texas at Austin \n \nSuicide is the 10th leading cause of death in the United States\, the only one of the top ten that is increasing in number year after year. This year there will likely be 50\,000 suicides in the United States (130 per day) and in addition approximately 20\,000 of the 70\,000 opiate overdose deaths each year are classified as suicides. It is the second leading cause of death in the 15-34 year age group. In spite of many public health and education efforts in the past decade\, suicide rates have continued to climb. Research on risk factors for suicide have been informative.  Men are at significantly greater risk for suicide than women. In addition other risk factors that have been clearly documented are a past diagnosis of depression or related psychiatric disorders\,  history of childhood maltreatment including bullying\, family history of suicide (underlying the genetic component of risk)\, alcohol and substance abuse\, as well as more recent life stressors such as loss of job\, a recent serious medical diagnosis\, imminent divorce and recent trauma. The reduction of available psychiatric inpatient beds is also associated with the year over year increase nationally. There is considerable evidence for an underlying neurobiological basis for suicidality including increased inflammation\, decreased activity of serotonergic circuits in the brain and increase activity of the major mammalian stress system\, the pituitary-adrenal axis. Certain medications including lithium and clozapine are known to reduce suicide as are  certain forms of cognitive-behavioral therapy (CBT). Finally providing obstacles to means of suicide has been shown to be effective in reducing suicide rates. \n  \n\nCharles B. Nemeroff\, MD\, PhD\, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research\, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin. \nHe received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill\, North Carolina. After psychiatry residency training at UNC and Duke University\, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009. \nHe has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America (ADAA). \nHe has received a number of research and education awards including the Kempf Award in Psychobiology\, the Samuel Hibbs Award\, Research Mentoring Award\,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA)\, the Mood Disorders Award\, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002. \nHe has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015. \nHis research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease\, diabetes and cancer. He has published more than 1100 research reports and reviews. \nHe has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg\, MD.) of the Textbook of Psychopharmacology\, published by the APA Press\, now in its Fifth Edition. \nHis research is currently supported by grants from the NIH. \n\nAdditional Talk: \nFriday\, Sept 13 – 12:00pm | WisPIC Commons Room\nPsychiatry Grand Rounds \nPrediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry \n \n\n  \nReading List: \n1. The Holy Grail of Psychiatry (2015) 81-89\n2. Understanding Depression – Contemporary Issues (2017) 21\, 245-261\n3. Psychosomatic Medicine (2014) 76\, 445-451
URL:https://www.psychiatry.wisc.edu/event/greenfield-memorial-lecture-2/
LOCATION:Webex
CATEGORIES:CME
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190920T120000
DTEND;TZID=America/Chicago:20190920T130000
DTSTAMP:20260525T105855
CREATED:20190416T154030Z
LAST-MODIFIED:20190712T160850Z
UID:3624-1568980800-1568984400@www.psychiatry.wisc.edu
SUMMARY:Charles B. Nemeroff\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Prediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry \n\nFRIDAY SEPT 13 | 12:00pm\nWisPIC Commons Room 1616\n6001 Research Park Blvd \nCharles B. Nemeroff\, MD\, PhD\nChair and Professor of Psychiatry\nDirector\, Institute for Early Childhood Adversity Research\nUniversity of Texas at Austin – Dell Medical School \nLearning Objectives \n\nTo understand the principles of personalized medicine as applied to mood and anxiety disorders.\nTo understand the role of Genome Wide Association Studies (GWAS)\, candidate gene approaches\, transcriptomics\, epigenetics\, and proteomics in predicting disease treatment response in mood and anxiety disorders.\nTo understand the potential for functional brain imaging for predicting treatment response in mood and anxiety disorders.\nTo understand the role of gene-environment interactions\, particularly early life trauma\, in predicting treatment response in mood disorders.\n\n\nCharles B. Nemeroff\, MD\, PhD\, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research\, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin. \nHe received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill\, North Carolina. After psychiatry residency training at UNC and Duke University\, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009. \nHe has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America \n  \nHe has received a number of research and education awards including the Kempf Award in Psychobiology\, the Samuel Hibbs Award\, Research Mentoring Award\,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA)\, the Mood Disorders Award\, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002. \nHe has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015. \nHis research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease\, diabetes and cancer. He has published more than 1100 research reports and reviews. \nHe has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg\, MD.) of the Textbook of Psychopharmacology\, published by the APA Press\, now in its Fifth Edition. \nHis research is currently supported by grants from the NIH.
URL:https://www.psychiatry.wisc.edu/event/grand-rounds-greenfield-speaker/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
END:VCALENDAR